2014 | HFSA

FDA Approves Expanded Indication for Certain Pacemakers and Defibrillators in HF

Practice News

The U.S. Food and Drug Administration today approved an application from Medtronic for  revised labeling for two cardiac resynchronization pacemakers (CRT-P) and eight cardiac resynchronization defibrillators (CRT-D), expanding the indication for use to patients with atrioventricular (AV) block and less severe heart failure.

Read the full FDA press release online.